Q32 Bio Inc.: Chief scientific officer Violette Shelia M. sold 917 shares

What happened

• Violette Shelia M., chief scientific officer, sold 917 shares in an open market or private sale on Oct 6, 2026, reported in a Form 4 filed Oct 14, 2026. The filing shows a weighted average price of $8.32 and total proceeds of $7,629.

Key details

• Transaction date and prices: Oct 6, 2026; weighted average price $8.32; prices ranged from $8.07 to $8.32 per footnote F2.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes of note:
  • F1: The shares sold were required to be sold to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units; the sales were automatic and not in the discretion of the reporting person.
  • F2: The reported price is a weighted average; the reporting person can provide a breakdown of the number of shares sold at each price on request.
  • F3: Some shares are held by Violette Holdings LLC; the reporting person is a manager of Violette Holdings and disclaims beneficial ownership except to the extent of any pecuniary interest.

Why it may matter

• The filing indicates this sale was to satisfy tax withholding on vested performance-based restricted stock units (an automatic sale related to vesting).
• This filing does not show why the insider traded or why the company acted.